NASDAQ:CDTX
$1.51
(
11.03%
)
Friday, 3rd Feb 2023
Cidara Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.731 | $1.63 | Friday, 3rd Feb 2023 CDTX stock ended at $1.51. This is 11.03% more than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 17.27% from a day low at $1.39 to a day high of $1.63. |
| 90 days | $0.460 | $1.63 | |
| 52 weeks | $0.400 | $1.63 |
Historical Cidara Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $1.40 | $1.63 | $1.39 | $1.51 | 2 954 268 |
| 2023-02-02 | $1.29 | $1.41 | $1.28 | $1.36 | 1 970 815 |
| 2023-02-01 | $1.23 | $1.31 | $1.19 | $1.29 | 1 771 912 |
| 2023-01-31 | $1.21 | $1.26 | $1.17 | $1.23 | 1 300 375 |
| 2023-01-30 | $1.21 | $1.28 | $1.16 | $1.21 | 1 627 690 |
| 2023-01-27 | $1.18 | $1.23 | $1.14 | $1.21 | 1 583 662 |
| 2023-01-26 | $1.23 | $1.35 | $1.15 | $1.21 | 4 239 768 |
| 2023-01-25 | $1.07 | $1.30 | $0.95 | $1.28 | 23 103 017 |
| 2023-01-24 | $0.93 | $0.93 | $0.93 | $0.93 | 0 |
| 2023-01-23 | $0.80 | $0.93 | $0.800 | $0.93 | 2 828 925 |
| 2023-01-20 | $1.32 | $1.40 | $0.750 | $0.783 | 8 179 475 |
| 2023-01-19 | $1.26 | $1.35 | $1.20 | $1.29 | 685 424 |
| 2023-01-18 | $1.46 | $1.50 | $1.18 | $1.27 | 1 696 673 |
| 2023-01-17 | $1.38 | $1.60 | $1.37 | $1.38 | 1 971 229 |
| 2023-01-13 | $1.22 | $1.33 | $1.21 | $1.32 | 1 207 606 |
| 2023-01-12 | $1.15 | $1.28 | $1.12 | $1.20 | 1 171 510 |
| 2023-01-11 | $0.98 | $1.12 | $0.95 | $1.12 | 615 503 |
| 2023-01-10 | $0.97 | $1.00 | $0.87 | $0.98 | 679 800 |
| 2023-01-09 | $0.86 | $1.02 | $0.82 | $0.94 | 1 110 200 |
| 2023-01-06 | $0.84 | $0.85 | $0.798 | $0.82 | 286 700 |
| 2023-01-05 | $0.82 | $0.83 | $0.763 | $0.83 | 437 148 |
| 2023-01-04 | $0.790 | $0.82 | $0.731 | $0.81 | 369 228 |
| 2023-01-03 | $0.775 | $0.80 | $0.731 | $0.750 | 514 914 |
| 2022-12-30 | $0.778 | $0.790 | $0.710 | $0.756 | 644 072 |
| 2022-12-29 | $0.641 | $0.780 | $0.631 | $0.755 | 431 157 |
| 2022-12-28 | $0.643 | $0.680 | $0.560 | $0.631 | 472 173 |
| 2022-12-27 | $0.651 | $0.700 | $0.647 | $0.661 | 449 709 |
| 2022-12-23 | $0.620 | $0.691 | $0.600 | $0.680 | 530 313 |
| 2022-12-22 | $0.530 | $0.675 | $0.502 | $0.625 | 853 870 |
| 2022-12-21 | $0.470 | $0.550 | $0.470 | $0.523 | 422 475 |
| 2022-12-20 | $0.490 | $0.497 | $0.465 | $0.476 | 313 454 |
| 2022-12-19 | $0.519 | $0.550 | $0.480 | $0.482 | 176 485 |
| 2022-12-16 | $0.506 | $0.518 | $0.486 | $0.487 | 219 289 |
| 2022-12-15 | $0.550 | $0.593 | $0.490 | $0.500 | 464 537 |
| 2022-12-14 | $0.540 | $0.590 | $0.530 | $0.542 | 266 887 |
| 2022-12-13 | $0.530 | $0.570 | $0.530 | $0.539 | 285 923 |
| 2022-12-12 | $0.480 | $0.580 | $0.480 | $0.527 | 265 469 |
| 2022-12-09 | $0.480 | $0.510 | $0.465 | $0.482 | 446 329 |
| 2022-12-08 | $0.561 | $0.561 | $0.460 | $0.483 | 824 538 |
| 2022-12-07 | $0.588 | $0.600 | $0.543 | $0.558 | 353 545 |
| 2022-12-06 | $0.590 | $0.600 | $0.560 | $0.588 | 211 476 |
| 2022-12-05 | $0.590 | $0.621 | $0.587 | $0.600 | 151 432 |
| 2022-12-02 | $0.640 | $0.655 | $0.585 | $0.599 | 374 309 |
| 2022-12-01 | $0.670 | $0.670 | $0.621 | $0.650 | 307 092 |
| 2022-11-30 | $0.677 | $0.677 | $0.610 | $0.640 | 319 406 |
| 2022-11-29 | $0.701 | $0.705 | $0.658 | $0.677 | 337 693 |
| 2022-11-28 | $0.740 | $0.740 | $0.690 | $0.710 | 354 472 |
| 2022-11-25 | $0.662 | $0.700 | $0.634 | $0.695 | 76 084 |
| 2022-11-23 | $0.689 | $0.732 | $0.660 | $0.665 | 445 506 |
| 2022-11-22 | $0.670 | $0.730 | $0.644 | $0.703 | 263 380 |
About Cidara Therapeutics
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive... CDTX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
